Organigram Global (OGI) Cash from Operations Growth (1y) (2019 - 2026)
Organigram Global (OGI) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.44 Bn | 30.50 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 425.00% |
| 10 | Organigram Global | 122.43 Mn | 155.50 Mn | 28.97 Mn | -43.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.67% |
| Dec 31, 2025 | -283.75% |
| May 31, 2021 | -100.24% |
| Feb 28, 2021 | -171,032,845.59% |
| Nov 30, 2020 | 834,397.74% |
| Aug 31, 2020 | -5,842,162.12% |
| May 31, 2020 | 380,385.64% |
| Feb 29, 2020 | -99.67% |
| Nov 25, 2019 | -164.18% |
| Aug 31, 2019 | -99.99% |